Roche Stops Developing a New Drug for Diabetes

Development of the drug, aleglitazar, was discontinued after Roche cited concerns about safety and effectiveness.

    

Powered by WPeMatico

Share
This entry was posted in World News. Bookmark the permalink.

Comments are closed.